Skip to main content
logo
Terns Pharmaceuticals, Inc. (TERN)
May 5, 2026 - TERN was delisted (reason: acquired by MRK)
52.95
+0.02 (0.04%)
Inactive · Last trade price on May 4, 2026

Terns Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-----1
Revenue Growth
------
Gross Profit
-----1
Operating Income
-110.12-110.12-101.87-102.56-62.03-49.86
Net Income
-96.21-96.21-88.85-90.21-60.35-50.16
Earnings Per Share
-1.03-1.03-1.12-1.27-1.67-2.21
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,0191,019358.16263.44283.11165.98
Total Debt
0.920.921.350.61.210.16
Net Cash (Debt)
1,0181,018356.82262.84281.91165.82
Net Cash Growth
185.32%185.32%35.76%-6.77%70.01%168.52%
Net Cash Per Share
10.9310.934.493.697.827.30

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-82.18-82.18-70.02-67.39-49.11-41.83
Capital Expenditures
---0.04-0.05-0.28-0.34
Free Cash Flow
-82.18-82.18-70.06-67.44-49.38-42.17
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-----100.00%
Operating Margin
------4986.00%
Pretax Margin
------4965.00%
Profit Margin
------5015.80%
FCF Margin
------4216.70%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-----178.65